Rubria Marines‐Price

ORCID: 0000-0001-8361-8233
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular and exercise physiology
  • COVID-19 Clinical Research Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • SARS-CoV-2 and COVID-19 Research
  • Body Composition Measurement Techniques
  • Long-Term Effects of COVID-19
  • Obesity, Physical Activity, Diet
  • Physical Activity and Health
  • Cardiovascular Effects of Exercise
  • Children's Physical and Motor Development
  • Heart Rate Variability and Autonomic Control
  • Obstructive Sleep Apnea Research
  • Respiratory Support and Mechanisms
  • Antibiotics Pharmacokinetics and Efficacy
  • Injury Epidemiology and Prevention
  • Health and Lifestyle Studies
  • Cardiovascular Disease and Adiposity
  • Music Therapy and Health
  • Sports Performance and Training
  • Pulmonary Hypertension Research and Treatments
  • Obesity and Health Practices
  • Asthma and respiratory diseases
  • Infectious Encephalopathies and Encephalitis
  • COVID-19 Impact on Reproduction
  • SARS-CoV-2 detection and testing

The University of Texas Southwestern Medical Center
2016-2024

Parkland Health & Hospital System
2018-2022

Stanford University
2022

Institute for Exercise and Environmental Medicine
2015-2019

Texas Health Dallas
2016-2019

Presbyterian Hospital
2018-2019

Valdosta State University
2016

Texas A&M University – Commerce
2016

Appalachian State University
2016

Thomas L Holland Adit A. Ginde Roger Paredes Thomas A. Murray Nicole Engen and 95 more Greg Grandits Andrew M. Vekstein Noel Ivey Ahmad Mourad Uriel Sandkovsky Robert Gottlieb Mezgebe Berhe Mamta K. Jain Rubria Marines‐Price Barbine Tchamba Agbor Agbor Lourdes Mateu Sergio España-Cueto Gemma Lladós Eleftherios Mylonakis Ralph Rogers Fadi Shehadeh Michael R. Filbin Kathryn A. Hibbert Kami Kim Thanh Tran Peter E. Morris Evan Cassity Barbara W. Trautner Lavannya M. Pandit Kirk U. Knowlton Lindsay Leither Michael A. Matthay Angela J. Rogers Wonder Drake Beatrice Jones Garyphallia Poulakou Konstantinos N. Syrigos Eduardo Fernández‐Cruz Marisa Di Natale Eyad Almasri Leire Balerdi-Sarasola Sanjay Bhagani Katherine L. Boyle Jonathan D. Casey Peter Chen David J. Douin D. Clark Files Huldrych F. Günthard R. Duncan Hite Robert C. Hyzy Akram Khan Moses Kibirige Robert Kidega Ivan Kimuli Francis Kiweewa Jens‐Ulrik Stæhr Jensen Bradley G. Leshnower Joseph Lutaakome Prasad Manian Vidya Menon José Luís Morales‐Rull D. Shane O’Mahony J. Scott Overcash Srikant Ramachandruni Jay S. Steingrub Hassan S. Taha Michael R. Waters Barnaby Edward Young Andrew Phillips Daniel D. Murray Tomas Ø. Jensen María L. Padilla David Sahner Kathryn Shaw‐Saliba Robin Dewar Marc Teitelbaum Ven Natarajan M. Tauseef Rehman Sarah Pett Fleur Hudson Giota Touloumi Samuel M. Brown Wesley H. Self Christina C. Chang Adriana Sánchez Amy Weintrob Timothy Hatlen Birgit Grund Shweta Sharma Cavan Reilly Pedro Garbes Mark T. Esser Alison Templeton Abdel G. Babiker Victoria J. Davey Annetine C. Gelijns Elizabeth S. Higgs Virginia L. Kan Gail Matthews Bruce Thompson

10.1016/s2213-2600(22)00215-6 article EN publisher-specific-oa The Lancet Respiratory Medicine 2022-07-08
Christina E. Barkauskas Eleftherios Mylonakis Garyphallia Poulakou Barnaby Edward Young David M. Vock and 95 more Lianne Siegel Nicole Engen Greg Grandits Nilima Mosaly Andrew M. Vekstein Ralph Rogers Fadi Shehadeh Matthew Kaczynski Evangelia K. Mylona Konstantinos N. Syrigos Vasiliki Rapti David Chien Lye Diong Shiau Hui Lindsay Leither Kirk U. Knowlton Mamta K. Jain Rubria Marines‐Price Alice Osuji J. Scott Overcash Ioannis Kalomenidis Zafeiria Barmparessou Michael R. Waters Karla Zepeda Peter Chen Sam Torbati Francis Kiweewa Nicholus Sebudde Eyad Almasri Alyssa Hughes Sanjay Bhagani Alison Rodger Uriel Sandkovsky Robert Gottlieb Nnakelu Eriobu Barbara W. Trautner Vidya Menon Joseph Lutaakome Michael A. Matthay Philip A. Robinson Konstantinos Protopapas Νikolaos Koulouris Ivan Kimuli Amiran Baduashvili Dominique L. Braun Huldrych F. Günthard Srikanth Ramachandruni Robert Kidega Kami Kim Timothy Hatlen Andrew Phillips Daniel D. Murray Tomas Ø. Jensen María L. Padilla Evan Accardi Kathryn Shaw‐Saliba Robin Dewar Marc Teitelbaum Ven Natarajan Sylvain Laverdure Helene C. Highbarger M. Tauseef Rehman Susan Vogel David Vallée Page Crew Negin Atri Adam Schechner Sarah Pett Fleur Hudson Jonathan Badrock Giota Touloumi Samuel M. Brown Wesley H. Self Crystal M. North Adit A. Ginde Christina C. Chang Anthony D. Kelleher Stephanie Nagy-Agren Shikha Vasudeva David P. Looney Hien Nguyen Adriana Sánchez Amy Weintrob Birgit Grund Shweta Sharma Cavan Reilly Roger Paredes Agnieszka Bednarska Norman P. Gerry Abdel G. Babiker Victoria J. Davey Annetine C. Gelijns Elizabeth S. Higgs Virginia L. Kan Gail Matthews B. Taylor Thompson

Ensovibep (MP0420) is a designed ankyrin repeat protein, novel class of engineered proteins, under investigation as treatment SARS-CoV-2 infection.To investigate if ensovibep, in addition to remdesivir and other standard care, improves clinical outcomes among patients hospitalized with COVID-19 compared care alone.Double-blind, randomized, placebo-controlled, trial. (ClinicalTrials.gov: NCT04501978).Multinational, multicenter trial.Adults COVID-19.Intravenous 600 mg, or placebo.Ensovibep was...

10.7326/m22-1503 article EN Annals of Internal Medicine 2022-08-08
Thomas L Holland Adit A. Ginde Roger Paredes Thomas A. Murray Nicole Engen and 95 more Greg Grandits Andrew M. Vekstein Noel Ivey Ahmad Mourad Uriel Sandkovsky Robert Gottlieb Mezgebe Berhe Mamta K. Jain Rubria Marines‐Price Barbine Tchamba Agbor Agbor Lourdes Mateu Sergio España-Cueto Gemma Lladós Eleftherios Mylonakis Ralph Rogers Fadi Shehadeh Michael R. Filbin Kathryn A. Hibbert Kami Kim Thanh Tran Peter E. Morris Evan Cassity Barbara W. Trautner Lavannya M. Pandit Kirk U. Knowlton Lindsay Leither Michael A. Matthay Angela J. Rogers Wonder Drake Beatrice Jones Garyphallia Poulakou Konstantinos N. Syrigos Eduardo Fernández‐Cruz Marisa Di Natale Eyad Almasri Leire Balerdi-Sarasola Sanjay Bhagani Katherine L. Boyle Jonathan D. Casey Peter Chen David J. Douin D. Clark Files Huldrych F. Günthard R. Duncan Hite Robert C. Hyzy Akram Khan Moses Kibirige Robert Kidega Ivan Kimuli Francis Kiweewa Jens‐Ulrik Stæhr Jensen Bradley G. Leshnower Joseph Lutaakome Prasad Manian Vidya Menon José Luís Morales‐Rull D. Shane O’Mahony J. Scott Overcash Srikant Ramachandruni Jay S. Steingrub Hassan S. Taha Michael R. Waters Barnaby Edward Young Andrew Phillips Daniel D. Murray Tomas Ø. Jensen María L. Padilla David Sahner Kathryn Shaw‐Saliba Robin Dewar Marc Teitelbaum Ven Natarajan M. Tauseef Rehman Sarah Pett Fleur Hudson Giota Touloumi Samuel M. Brown Wesley H. Self Christina C. Chang Adriana Sánchez Amy Weintrob Timothy Hatlen Birgit Grund Shweta Sharma Cavan Reilly Pedro Garbes Mark T. Esser Alison Templeton Abdel G. Babiker Victoria J. Davey Annetine C. Gelijns Elizabeth S. Higgs Virginia L. Kan Gail Matthews Bruce Thompson

Background: Tixagevimab/cilgavimab is a neutralising monoclonal antibody combination hypothesized to improve outcomes for hospitalised COVID-19 patients.Methods: In phase 3, blinded, randomised, placebo-controlled trial, adults at 81 sites on four continents were assigned receive intravenous tixagevimab 300 mg/cilgavimab mg or placebo, in addition remdesivir and other standard care. The primary outcome was time sustained recovery through day 90, defined as 14 consecutive days home after...

10.2139/ssrn.4087355 article EN SSRN Electronic Journal 2022-01-01

Background The ventilatory response to exercise is temporarily augmented in environmentally (e.g., breathing apparatus) or physiologically altered conditions respiratory disease), maintaining constant relative arterial PCO 2 regulation from rest exercise; this augmentation called short‐term modulation (STM) of the exercise. Obesity and/or obstructive sleep apnea could affect and STM capacity due additional mechanical load on system repetitive intermittent hypoxia during sleep. We...

10.1096/fasebj.30.1_supplement.1261.15 article EN The FASEB Journal 2016-04-01

The emergence of the COVID-19 pandemic required an immediate global clinical research response. ACTIV (Accelerating Therapeutic Interventions and Vaccines)-3 trials ACTIV-associated Outpatient Treatment with Anti-Coronavirus Immunoglobulin trial used Good Participatory Practices (GPP) to develop materials for study implementation from a network perspective. GPP guidelines offer framework engaging stakeholders throughout process. This paper provides overview developed their applicability in...

10.1017/cts.2024.485 article EN cc-by-nc-nd Journal of Clinical and Translational Science 2024-01-01

VO2peak is one of the most frequently determined cardiopulmonary exercise test parameters for assessment cardiorespiratory fitness (CRF). However, expressing relative to body weight may underestimate CRF in obese children due large inert fat mass load that they carry. PURPOSE: The purpose this study was examine different methods quantifying 10 and 11 yr old children. METHODS: Ten (11.3 ± 0.6 yr, ht: 149 7 cm, wt: 63 14 kg, BMI percentile 97 1) nine non-obese (10.7 0.4 142 5 36 4 56 19)...

10.1249/01.mss.0000477236.52692.9c article EN Medicine & Science in Sports & Exercise 2015-05-01

Introduction Dyspnea on exertion (DOE) is a common complaint in otherwise healthy obese women, which may influence and prevent them from engaging physical activity. DOE composed of at least two dimensions: sensory (i.e., intensity) affective emotional response). We examined whether subjective ratings breathlessness (RPB) during exercise were associated with unpleasantness negative emotions, including depression, anxiety, frustration, anger, fear. Methods Otherwise healthy, women underwent...

10.1096/fasebj.30.1_supplement.1288.23 article EN The FASEB Journal 2016-04-01

PURPOSE: Dyspnea on exertion (DOE) is a common symptom in otherwise healthy obese individuals and patients with serious illness. Whether have an exaggerated rating of breathlessness (RPB) as compared nonobese unknown. In retrospective analysis, we investigated RPB who were referred for clinical cardiopulmonary exercise testing (CPET) due to unexplained DOE. METHODS: Data from 112 separated into (BMI < 30; n = 28; 20 F) ≥ 47; 24 groups. All cycled at two individualized constant load work...

10.1249/01.mss.0000517762.51739.8d article EN Medicine & Science in Sports & Exercise 2017-05-01

PURPOSE: The purpose of this study was to examine dyspnea intensity, descriptors, and associated negative symptoms during exercise in 10 11 year old obese nonobese children. METHODS: 12 (9 boys, age: 11.3 ± 0.6y, height: 149.7 6.7cm, mass: 65.8 14.4kg, BMI percentile: 97.5 1.4, body fat: 46 3%) (5 10.8 0.5y, 143.3 5.2cm, 35.8 3.8kg, 50.3 21.5, 27 6%) underwent 3 constant load tests for 6 minutes each (at 40W, 50% VO2max, VO2max + 20W), a maximal test. Ratings perceived breathlessness (RPB),...

10.1249/01.mss.0000486367.62559.11 article EN Medicine & Science in Sports & Exercise 2016-05-01

Introduction The purpose of this case series was to investigate the respiratory effects weight loss or gain in obese children over 1 yr. Methods Two filled out physical activity questionnaire for (PAQ‐C) and underwent pulmonary function testing, dual‐energy x‐ray absorptiometry, maximal exercise constant load cycling at 40W before after either yr of: 1) training loss, 2) free‐living gain. were not provided with a supervised intervention Results Subject girl, age 11.8yr, who engaged program...

10.1096/fasebj.30.1_supplement.687.5 article EN The FASEB Journal 2016-04-01

PURPOSE Not only is fat weight greater in comparisons between nonobese and obese adults but also lean body mass (LBM). In a retrospective analysis, we investigated whether LBM increases with the magnitude of women. We hypothesized that would increase proportion to size. METHODS As part other studies, 207 otherwise healthy women 20 45 yr. had composition determinations by hydrostatic weighing. The subjects were grouped based on their percent (%BF): 1=30≤%BF&lt;40, n=25; 2= 40≤%BF&lt;45, n=54;...

10.1096/fasebj.30.1_supplement.686.10 article EN The FASEB Journal 2016-04-01

PURPOSE: The effects of adult obesity on lung function at rest, such as reductions in functional residual capacity and expiratory reserve volume, are well recognized. However, the operational volumes while lying supine, during exercise obese children unknown but could create meaningful respiratory limitations. METHODS: 11 nonobese (Ht: 143.3±5.2 cm; Wt: 35.8±3.8 kg; BMI percentile: 50±21; Body fat: 27±6%) 12 149.7±6.7 65.8±14.4 97.5±1.4; 46±3%) underwent dual energy x-ray absorptiometry,...

10.1249/01.mss.0000516855.81093.fc article EN Medicine & Science in Sports & Exercise 2017-05-01

HISTORY: A 67-year-old former marathon runner with a history of venous thromboembolism was referred for cardiopulmonary exercise testing (CPET) dyspnea on exertion (DOE), drop in fitness, and pre-surgical evaluation pulmonary thromboendarterectomy (PTE). He diagnosed chronic thromboembolic (CTE) disease 3 months prior to referral. His V/Q scan showed multiple perfusion defects. Normal spirometry, lung volumes, diffusion capacity. Right heart catheterization (RHC): RA 5 mm Hg; PA 37/15 Hg...

10.1249/01.mss.0000518375.23537.f1 article EN Medicine & Science in Sports & Exercise 2017-05-01

PURPOSE: Cardiorespiratory fitness (CRF) is used as a diagnostic and prognostic health indicator for all-cause cardiovascular disease mortality (Lee et al, 2010). Thus, properly quantifying interpreting CRF important accurate diagnoses. The current EACPR/AHA Scientific Statement includes peak oxygen uptake (VO2peak) both in ml/min/kg percent of predicted (Guazzi 2016).We have previously shown, small cohort otherwise healthy obese women (n = 26), that adults normal or slightly reduced (~85%...

10.1249/01.mss.0000536423.97295.44 article EN Medicine & Science in Sports & Exercise 2018-05-01

PURPOSE: Efficiency refers to the amount of work performed for a given energy consumption. Excess body weight is known increase resting oxygen uptake, but not net uptake or mechanical efficiency during non-weight bearing exercise such as cycling in prepubertal children. We examined whether V˙O2/WR slopes incremental were affected by changes composition after 1 year normal and obese 10-12 year-old METHODS: 17 children (9 obese) underwent an test on cycle ergometer dual x-ray absorptiometry at...

10.1249/01.mss.0000536022.66431.dd article EN Medicine & Science in Sports & Exercise 2018-05-01

INTRODUCTION Breathlessness during exercise, or dyspnea on exertion (DOE), is a common complaint in otherwise healthy obese adults. It possible that the higher perception of breathlessness due to work breathing. Thus, we investigated whether men with high DOE (+DOE) have breathing (i.e., oxygen cost) than low (−DOE). METHODS 27 underwent underwater weighing and 6‐min constant load submaximal cycling exercise at 105 W. They also performed eucapnic voluntary hyperpnea (EVH) determine cost...

10.1096/fasebj.2018.32.1_supplement.913.10 article EN The FASEB Journal 2018-04-01

PURPOSE: We have previously shown that weight loss improved dyspnea on exertion in obese, otherwise healthy, women. Dyspnea is a multidimensional symptom comprised of at least two distinct domains: sensory-perceptual (i.e., intensity) and affective distress unpleasantness emotional response). Both domains may lead individuals to avoid exercise. In this retrospective study, we investigated the effects obese women men these domains. |METHODS: Twenty-one participants (12 M/9 F, 33 ± 7 yrs, 169...

10.1249/01.mss.0000562105.73069.ce article EN Medicine & Science in Sports & Exercise 2019-06-01
Coming Soon ...